TIAA Trust National Association Sells 253 Shares of CME Group Inc. (NASDAQ:CME)

TIAA Trust National Association trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME) by 8.0% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 2,920 shares of the financial services provider’s stock after selling 253 shares during the period. TIAA Trust National Association’s holdings in CME Group were worth $574,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in CME. Norges Bank purchased a new position in shares of CME Group during the fourth quarter valued at approximately $959,260,000. Capital International Investors lifted its holdings in shares of CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares during the last quarter. PineStone Asset Management Inc. lifted its holdings in shares of CME Group by 137.6% during the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock valued at $444,443,000 after purchasing an additional 1,309,097 shares during the last quarter. Capital Wealth Planning LLC purchased a new position in shares of CME Group during the fourth quarter valued at approximately $253,563,000. Finally, Capital World Investors lifted its holdings in shares of CME Group by 8.7% during the fourth quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after purchasing an additional 1,172,575 shares during the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on CME shares. Keefe, Bruyette & Woods boosted their price objective on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Piper Sandler restated an “overweight” rating and issued a $225.00 price objective on shares of CME Group in a report on Tuesday, August 20th. Bank of America lowered shares of CME Group from a “neutral” rating to an “underperform” rating and decreased their price objective for the stock from $212.00 to $177.00 in a report on Tuesday. Barclays boosted their price objective on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a report on Thursday, July 25th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Four investment analysts have rated the stock with a sell rating, five have issued a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $209.73.

Insider Activity

In other news, Director Charles P. Carey sold 3,000 shares of the firm’s stock in a transaction on Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the sale, the director now directly owns 7,163 shares in the company, valued at approximately $1,399,936.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Charles P. Carey sold 3,000 shares of the firm’s stock in a transaction on Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the sale, the director now directly owns 7,163 shares in the company, valued at approximately $1,399,936.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.

CME Group Stock Up 1.6 %

CME opened at $219.38 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $223.80. The company has a market capitalization of $78.99 billion, a PE ratio of 24.96, a PEG ratio of 6.51 and a beta of 0.52. The firm’s 50 day simple moving average is $203.03 and its two-hundred day simple moving average is $207.56.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, topping the consensus estimate of $2.53 by $0.03. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company’s quarterly revenue was up 12.7% on a year-over-year basis. During the same period last year, the firm earned $2.30 earnings per share. As a group, equities analysts forecast that CME Group Inc. will post 9.89 EPS for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th will be given a dividend of $1.15 per share. The ex-dividend date is Monday, September 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.10%. CME Group’s payout ratio is 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.